Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 129 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NHU QM, Chiao H, Moawad FJ, Bao F, et al
    The Anti-alpha4beta7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0145.
    PubMed     Text format    


  2. LEVENSTEIN S, Prantera C
    Depression and Disease Course in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0111.
    PubMed     Text format    


  3. MAO R, Chen MH
    Networked Clinical Study Collaboration on Inflammatory Bowel Disease in China.
    Am J Gastroenterol. 2018 Jun 7. pii: 10.1038/s41395-018-0148.
    PubMed     Text format    


    May 2018
  4. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0057.
    PubMed     Text format     Abstract available


    April 2018
  5. MATSUSHITA M, Fukata N, Omiya M, Nishio A, et al
    Pathophysiology of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:622.
    PubMed     Text format    


    March 2018
  6. JENSEN CB, Angquist LH, Mendall MA, Sorensen TIA, et al
    Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0031.
    PubMed     Text format     Abstract available


  7. DEEKE SA, Starr AE, Ning Z, Ahmadi S, et al
    Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis.
    Am J Gastroenterol. 2018 Mar 12. pii: 10.1038/s41395-018-0024.
    PubMed     Text format     Abstract available


  8. VEERAPPAN GR
    Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018;113:404.
    PubMed     Text format    


    February 2018
  9. DAI C, Jiang M, Cao Q
    Association between Depression and More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0016.
    PubMed     Text format    


  10. CHAPARRO M, Verreth A, Lobaton T, Gravito-Soares E, et al
    Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg2017501. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  11. GRACIE DJ, Hamlin PJ, Ford AC
    Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0021.
    PubMed     Text format     Abstract available


  12. DULAI PS, Buckey JC Jr., Raffals LE, Swoger JM, et al
    Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0005.
    PubMed     Text format     Abstract available


  13. BARNES EL, Kappelman MD
    Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.
    Am J Gastroenterol. 2018;113:273-275.
    PubMed     Text format     Abstract available


  14. TOMINAGA K, Tsuchiya A, Honda Y, Abe T, et al
    A Case of Panenteritis With Massive IgG4-Positive Plasma Cell Infiltration Developed 26 Years After Total Proctocolectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:173.
    PubMed     Text format    


    January 2018
  15. LEWIS JD, Scott FI, Brensinger CM, Roy JA, et al
    Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jan 16. pii: ajg2017479. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  16. JEURING SFG, Biemans VBC, van den Heuvel TRA, Zeegers MP, et al
    Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2018 Jan 9. pii: ajg2017482. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    December 2017
  17. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  18. MA C, Moran GW, Benchimol EI, Targownik LE, et al
    Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.
    Am J Gastroenterol. 2017;112:1840-1848.
    PubMed     Text format     Abstract available


    November 2017
  19. KOCHAR B, Barnes EL, Long MD, Cushing KC, et al
    Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  20. CLICK B, Anderson AM, Koutroubakis IE, Rivers CR, et al
    Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.
    Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  21. BERNSTEIN CN, Kornbluth A
    Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1719-1721.
    PubMed     Text format     Abstract available


  22. ABE K, Nakamura N, Isono A, Toyota H, et al
    Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
    Am J Gastroenterol. 2017;112:1636.
    PubMed     Text format    


    October 2017
  23. MARTIN L, Peche W, Peterson K, Wan Y, et al
    Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available



  24. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  25. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  26. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    



  27. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed     Text format    


  28. FISCHER S, Rath T, Geppert CI, Manger B, et al
    Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1621-1623.
    PubMed     Text format    


  29. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


  30. BUCHNER AM, Lichtenstein GR
    Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Am J Gastroenterol. 2017;112:1593-1595.
    PubMed     Text format     Abstract available


  31. KHANNA R, Zou G, Stitt L, Feagan BG, et al
    Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Am J Gastroenterol. 2017;112:1584-1592.
    PubMed     Text format     Abstract available


    September 2017
  32. ESTEVEZ-BOULLOSA P, Fernandez-Fernandez N, Pineda-Marino JR, Martinez-Cadilla J, et al
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1363.
    PubMed     Text format    


  33. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017;112:1485.
    PubMed     Text format     Abstract available


    August 2017
  34. GHIONE S, Sarter H, Fumery M, Armengol-Debeir L, et al
    Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    July 2017
  35. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017 Jul 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  36. YAMADA A, Komaki Y, Patel N, Komaki F, et al
    Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  37. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  38. DAI C, Jiang M, Sun MJ
    The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1165.
    PubMed     Text format    


  39. MATSUSHITA M, Fukata N, Omiya M, Okazaki K, et al
    Nationwide Studies of Hematological Malignancies in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1171-1172.
    PubMed     Text format    


    June 2017
  40. MYRELID P, Landerholm K, Nordenvall C, Pinkney TD, et al
    Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study.
    Am J Gastroenterol. 2017 Jun 27. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  41. PATIL DT, Odze RD
    Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jun 20. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  42. KOMEDA Y, Kashida H, Sakurai T, Kono M, et al
    A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:833.
    PubMed     Text format    


    May 2017
  43. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  44. CHAPARRO M, Ramas M, Benitez JM, Lopez-Garcia A, et al
    Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    April 2017
  45. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    March 2017
  46. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed     Text format    


  47. LIMSRIVILAI J, Shreiner AB, Pongpaibul A, Laohapand C, et al
    Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Am J Gastroenterol. 2017;112:415-427.
    PubMed     Text format     Abstract available


    February 2017
  48. FUMERY M, Seksik P, Auzolle C, Munoz-Bongrand N, et al
    Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Am J Gastroenterol. 2017;112:337-345.
    PubMed     Text format     Abstract available


  49. JEURING SF, van den Heuvel TR, Liu LY, Zeegers MP, et al
    Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2017;112:325-336.
    PubMed     Text format     Abstract available


    January 2017
  50. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  51. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format    


  52. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  53. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed     Text format    


  54. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed     Text format    


    December 2016
  55. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  56. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed     Text format    


    November 2016
  57. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed     Text format    


    October 2016
  58. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  59. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available



  60. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  61. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  62. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    



  63. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed     Text format    


  64. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed     Text format    


  65. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Text format     Abstract available


    September 2016
  66. UNGARO R, Chang HL, Cote-Daigneaut J, Mehandru S, et al
    Corrigendum: Statins Associated with Decreased Risk of New Onset Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1370.
    PubMed     Text format    


    August 2016
  67. CHEDDANI H, Dauchet L, Fumery M, Charpentier C, et al
    Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  68. BILLIET T, Dreesen E, Cleynen I, Wollants WJ, et al
    A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  69. LEVIN SR, Ziud H, Jimoh OY, Tseng YA, et al
    Ulcerative Colitis Presenting With Palmoplantar Neutrophilic Dermatosis.
    Am J Gastroenterol. 2016;111:923.
    PubMed     Text format    


    June 2016
  70. WANG LH, Yang YJ, Cheng WC, Wang WM, et al
    Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Am J Gastroenterol. 2016 Jun 14. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  71. UNGARO R, Chang HL, Cote-Daigneaut J, Mehandru S, et al
    Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Jun 14. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  72. MARIN-JIMENEZ I, Nos P, Domenech E, Riestra S, et al
    Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Am J Gastroenterol. 2016;111:912.
    PubMed     Text format    


  73. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed     Text format    


    May 2016
  74. RAZIK R, Rumman A, Bahreini Z, McGeer A, et al
    Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Am J Gastroenterol. 2016 May 24. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  75. DEEPAK P, Fletcher JG, Fidler JL, Barlow JM, et al
    Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  76. TARIQ R, Smyrk T, Pardi DS, Tremaine WJ, et al
    New-Onset Microscopic Colitis in an Ulcerative Colitis Patient After Fecal Microbiota Transplantation.
    Am J Gastroenterol. 2016;111:751-2.
    PubMed     Text format    


  77. YZET C, Dupas JL, Fumery M
    Ustekinumab and Anti-TNF Combination Therapy in Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:748-9.
    PubMed     Text format    


    April 2016
  78. NEGRON ME, Rezaie A, Barkema HW, Rioux K, et al
    Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.
    Am J Gastroenterol. 2016 Apr 19. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    March 2016
  79. GULAMHUSEIN AF, Eaton JE, Tabibian JH, Atkinson EJ, et al
    Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  80. GRACIE DJ, Williams CJ, Sood R, Mumtaz S, et al
    Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  81. GISBERT JP, Marin AC, Chaparro M
    The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Mar 22. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  82. ZENLEA T, Yee EU, Rosenberg L, Boyle M, et al
    Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  83. KABBANI TA, Koutroubakis IE, Schoen RE, Ramos-Rivers C, et al
    Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study.
    Am J Gastroenterol. 2016 Mar 8. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  84. PILLET S, Williet N, Pouvaret A, Del Tedesco E, et al
    Distribution of Cytomegalovirus DNA Load in the Inflamed Colon of Ulcerative Colitis Patients.
    Am J Gastroenterol. 2016;111:439-41.
    PubMed     Text format    


  85. MUIR A, Surrey L, Kriegermeier A, Shaikhkalil A, et al
    Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.
    Am J Gastroenterol. 2016;111:437-8.
    PubMed     Text format    


  86. KAPLAN GG
    Smoking Cessation for Crohn's Disease: Clearing the Haze.
    Am J Gastroenterol. 2016;111:420-2.
    PubMed     Text format     Abstract available


  87. NUNES T, Etchevers MJ, Garcia-Sanchez V, Ginard D, et al
    Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.
    Am J Gastroenterol. 2016;111:411-9.
    PubMed     Text format     Abstract available


    February 2016
  88. NARULA N, Marshall JK, Colombel JF, Leontiadis GI, et al
    Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Am J Gastroenterol. 2016 Feb 9. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  89. CZUL F, Beduschi T, Deshpande AR
    Image of the Month: A Small Bowel With Too Many Exits: An Astonishing Surgical Finding in a Patient With Crohn's Disease.
    Am J Gastroenterol. 2016;111:172.
    PubMed     Text format    


    January 2016
  90. MARIN-JIMENEZ I, Nos P, Domenech E, Riestra S, et al
    Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Am J Gastroenterol. 2016 Jan 12. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  91. SVRCEK M, Beaugerie L, Kirchgesner J, Dumont S, et al
    Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:149-51.
    PubMed     Text format    


  92. PARK KT, Colletti RB, Rubin DT, Sharma BK, et al
    Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
    Am J Gastroenterol. 2016;111:15-23.
    PubMed     Text format     Abstract available


    November 2015
  93. PAUL S, Roblin X
    Response to Steenholdt.
    Am J Gastroenterol. 2015;110:1624-5.
    PubMed     Text format    


  94. STEENHOLDT C
    Transient and Persistent Antibodies Against TNF-Inhibitors in IBD.
    Am J Gastroenterol. 2015;110:1623-4.
    PubMed     Text format    


  95. BOLAND BS, Dulai PS, Chang M, Sandborn WJ, et al
    Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.
    Am J Gastroenterol. 2015;110:1631-2.
    PubMed     Text format    


    October 2015
  96. BEWTRA M, Fairchild AO, Gilroy E, Leiman DA, et al
    Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.
    Am J Gastroenterol. 2015 Oct 20. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available



  97. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2015;110 Suppl 1:S766-847.
    PubMed     Text format    


  98. KISIEL JB, Loftus EV
    Editorial: Clarity and Caution in the Natural History of Low-Grade Dysplasia in Ulcerative Colitis.
    Am J Gastroenterol. 2015;110:1473-4.
    PubMed     Text format     Abstract available


  99. FUJITA T
    An unexpected inverse association between colon adenomas and colitis.
    Am J Gastroenterol. 2015;110:1508-9.
    PubMed     Text format    


  100. CASSELL B, Gyawali CP, Kushnir VM, Gott BM, et al
    Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients.
    Am J Gastroenterol. 2015;110:1382-7.
    PubMed     Text format     Abstract available


    September 2015
  101. CHOI CR, Ignjatovic-Wilson A, Askari A, Lee GH, et al
    Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal Cancer.
    Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  102. SAHAMI S, Kooij IA, Meijer SL, Van den Brink GR, et al
    The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms.
    Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  103. KANTSO B, Simonsen J, Hoffmann S, Valentiner-Branth P, et al
    Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
    Am J Gastroenterol. 2015 Sep 8. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  104. YAMAMOTO T, Shimoyama T
    Can Fecal Biomarkers Detect Ileal Inflammation in Inflammatory Bowel Disease?
    Am J Gastroenterol. 2015;110:1370.
    PubMed     Text format    


  105. BENCHIMOL EI, Mack DR, Nguyen GC
    Response to Fuller-Thomson.
    Am J Gastroenterol. 2015;110:1371-2.
    PubMed     Text format    


  106. FULLER-THOMSON ER
    Incidence of IBD Among Immigrants to Canada and Their Children: Could Gluten Consumption and Celiac Disease Partly Explain the Variation?
    Am J Gastroenterol. 2015;110:1370-1.
    PubMed     Text format    


    August 2015
  107. PEYRIN-BIROULET L, Sandborn W, Sands BE, Reinisch W, et al
    Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
    Am J Gastroenterol. 2015 Aug 25. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  108. DAI C, Jiang M, Sun MJ
    The Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS.
    Am J Gastroenterol. 2015;110:1242-3.
    PubMed     Text format    


  109. MENEES S, Powell C, Chey WD
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1243-4.
    PubMed     Text format    


  110. BOSCHETTI G, Drai J, Flourie B, Nancey S, et al
    Response to Dai et al.
    Am J Gastroenterol. 2015;110:1242.
    PubMed     Text format    


  111. DAI C, Jiang M, Sun MJ
    Levels of fecal calprotectin and the severity of postoperative patients with Crohn's disease.
    Am J Gastroenterol. 2015;110:1241-2.
    PubMed     Text format    


    July 2015
  112. KOPYLOV U, Yablecovitch D, Lahat A, Neuman S, et al
    Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn's Disease Using Biomarkers, Capsule Endoscopy, and Imaging.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  113. FRELING E, Baumann C, Cuny JF, Bigard MA, et al
    Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience.
    Am J Gastroenterol. 2015 Jul 21. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  114. HIGGINS PD
    Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?
    Am J Gastroenterol. 2015;110:1035-7.
    PubMed     Text format     Abstract available


  115. SONNENBERG A, Genta RM
    Low Prevalence of Colon Polyps in Chronic Inflammatory Conditions of the Colon.
    Am J Gastroenterol. 2015;110:1056-61.
    PubMed     Text format     Abstract available


    June 2015
  116. TARGOWNIK LE, Sexton KA, Bernstein MT, Beatie B, et al
    The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2015 Jun 16. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  117. CHRISTENSEN KR, Steenholdt C, Buhl SS, Ainsworth MA, et al
    Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFalpha Therapy.
    Am J Gastroenterol. 2015 Jun 2. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  118. VAN ASSCHE G, Manguso F, Zibellini M, Nuno JL, et al
    Corrigendum: Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study.
    Am J Gastroenterol. 2015;110:943.
    PubMed     Text format    


  119. SCHOEPFER A, Reinisch W
    Editorial: Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed?
    Am J Gastroenterol. 2015;110:888-90.
    PubMed     Text format     Abstract available


  120. MAGRO F, Rodrigues-Pinto E, Coelho R, Andrade P, et al
    Response to Irwin et al.
    Am J Gastroenterol. 2015;110:933-5.
    PubMed     Text format    


  121. IRWIN J, Radford-Smith G
    Response to Magro et al.
    Am J Gastroenterol. 2015;110:931-2.
    PubMed     Text format    


  122. BOSCHETTI G, Laidet M, Moussata D, Stefanescu C, et al
    Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Am J Gastroenterol. 2015;110:865-72.
    PubMed     Text format     Abstract available


    May 2015
  123. KOLHO KL, Korpela K, Jaakkola T, Pichai MV, et al
    Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
    Am J Gastroenterol. 2015 May 19. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  124. MOSLI MH, Zou G, Garg SK, Feagan SG, et al
    C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2015 May 12. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  125. PAUL S, Dronne W, Roblin X
    Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBD.
    Am J Gastroenterol. 2015;110:777-8.
    PubMed     Text format    


    April 2015
  126. LINDOR KD, Kowdley KV, Harrison ME
    ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2015 Apr 14. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  127. PAREKH PJ, Oldfield Iv EC, Challapallisri V, Ware JC, et al
    Sleep disorders and inflammatory disease activity: chicken or the egg?
    Am J Gastroenterol. 2015;110:484-8.
    PubMed     Text format     Abstract available


    March 2015
  128. PAUL S, Roblin X
    Response to Bodini et al.
    Am J Gastroenterol. 2015;110:473.
    PubMed     Text format    


  129. HIGGINS PD, Fletcher JG
    Editorial: characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.
    Am J Gastroenterol. 2015;110:441-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: